CA Patent

CA3232053A1 — Nucleic acids containing abasic nucleosides

Assigned to E Therapeutics PLC · Expires 2023-04-13 · 3y expired

What this patent protects

The present invention relates to nucleic acid molecules for use in the treatment or prevention of disease.

USPTO Abstract

The present invention relates to nucleic acid molecules for use in the treatment or prevention of disease.

Drugs covered by this patent

plozasiran-sodium (PLOZASIRAN SODIUM)

Patent Metadata

Patent number: CA3232053A1
Jurisdiction: CA
Classification: —
Expires: 2023-04-13
Drug substance claim: No
Drug product claim: No
Assignee: E Therapeutics PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.